Calcium-channel blockers prevent endothelin-induced systemic hypertension but do not protect against endothelin-induced renal vasoconstriction and GFR reduction in animal models.
No takes yet. Share an insight, caveat, or question.
CCBs may not preserve GFR despite controlling endothelin-driven hypertension in animals; leaves open whether this dissociation holds in human disease.
Cao et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: